The data show that all the breast cancer cell lines express varying levels of IL-6, CAP1 and IL-6R (Supplementary Fig. 1), whereas no expression of resistin is observed either at the protein or transcript level in any of the cell lines (data not shown). This evidence concerns the gene CAP1 and breast carcinoma.